Specialty Pharmacy News

Image description

FDA approves Genzyme MS treatment

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.